News About: Pharm. Affairs


6,400 hospitals and clinics and 7,100 pharmacies opening during Chuseok holidays in Korea

The Ministry of Health and Welfare(Minister Neung-Hoo Park, MOHW) announced to provide information about hospitals, clinics and pharmacies to minimize inconvenience and prevent overcrowding for emergency rooms by lett...

Number of pharmacists short of about 7 thousand within 3 years, MOHW considers to increase pharmacist students

As it was suggested that the number of pharmacists would not be enough to the population in the future, the Ministry of Health and Welfare(MOHW) is reportedly reviewing to increase the maximum number of students in co...

KPA decides to form ‘Special Committee for International Nonproprietary Names Program’

The Korean Pharmaceutical Association(President Chan-Hwi Cho, KPA) held the 9th Executive Directors’ meeting for the year of 2017 on the 21st and decided to form the ‘Special Committee for the International Nonproprie...

Recruitment of clinical trial applications addressed in smart phones

Korea is a powerful country in clinical trials and has the highest smart phone and high-speed Internet distribution rates. Unlike its status, however, the country has no integrated clinical trial information and is li...

Expert Committee, ‘We accepts importance of creating legal bases for off-label uses’

Importance of creating a revision bill to the Pharmaceutical Affairs Law, which create a base to evaluate safety and efficacy about off-label use of pharmaceutical drugs, was accepted. Young-Hwan Seok, a senior exper...

Keytruda Inj and Opdivo Inj approved promptly for off-label use

The Health Insurance Review & Assessment Service(President Seung-Taek Kim, HIRA) decided to approve off-label uses of Keytruda Inj(generic name: pembrolizumab) and Opdivo Inj(generic name: nivolumab), immune checkpoin...

‘Prohibition of advertisements for OTC drugs consumed as ETC is immoderate’

An opinion was shared that a bill to prohibit advertisements for OTC drugs that are similar to a ETC drug is an immoderate regulation. Young-Hwan Seok, a senior expert member at the Health and Welfare Committee, said...

Medicine- or drug-related names can only be used by drug manufacturers or sellers from December

Every business owner, but pharmaceutical manufactures and sellers, will be imposed a fine for using a name similar to medicine and drug from the coming December. The Ministry of Food and Drug Safety gave a pre-announ...

Registered medicines are now available to acquire separate approval as orphan drug

In order to promote manufacturing of orphan drugs, a system will be improved for already registered medicines to acquire separate product approval as am orphan drug. The Minister of Food and Drug Safety(Minister Youn...

“They need to understand International Nonproprietary Names is an international trend”

The Korean Pharmaceutical Association(President Chan-Hwi Cho, KPA) criticized the Korean Medical Association’s(KMA) argument about the ‘International Nonproprietary Names(INN)’ program was ‘implausible,’ and gave a cr...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.